Back to list page

£2.7m awarded to respiratory disease innovations

Posted: 19th January 2023

SBRI Healthcare in partnership with Asthma + Lung UK has awarded £2.7 million to six innovations that support people with respiratory diseases. Currently, 1 in 5 people are diagnosed with a respiratory disease. It is the third biggest cause of death in England, after cancer and cardiovascular disease.

This funding is part of an Accelerated Access Collaborative initiative in partnership with the AHSN Network, which has awarded £6 million to 14 late-stage innovations that help detect, prevent and manage Cardiovascular Disease (CVD) and respiratory disease.

Yorkshire & Humber Academic Health Science Network (Yorkshire & Humber AHSN) is proud to be part of the Lenus Health project, one of the innovation projects that has been awarded funding.

The project is implementing and evaluating the Lenus support service for remotely managing chronic obstructive pulmonary disease (COPD) throughout Hull University Teaching Hospitals NHS Trust (HUTH).

Yorkshire & Humber AHSN will continue to be part of the oversight group, advising on benefits realisation and further spread of the innovation across the Yorkshire and Humber region.

About Lenus Health

The Lenus COPD Support Service leverages data from connected devices and patient-reported outcomes and enables messaging to the clinical team, in real time. The service aims to reduce hospitalisations through more timely interventions and has been a catalyst for joining up care by supporting shared decision-making among healthcare practitioners and patients.

Further information

SBRI Healthcare is an Accelerated Access Collaborative (AAC) initiative – a partnership between patient groups, government bodies, industry and the NHS hosted by NHS England – and is delivered in partnership with the AHSN Network.

Find out more about the other innovations recognised.